KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Exchange Rate Effect (2016 - 2025)

Charles River Laboratories International (CRL) has 17 years of Exchange Rate Effect data on record, last reported at $3.9 million in Q4 2025.

  • For Q4 2025, Exchange Rate Effect rose 129.21% year-over-year to $3.9 million; the TTM value through Dec 2025 reached $18.8 million, up 207.75%, while the annual FY2025 figure was $18.8 million, 207.75% up from the prior year.
  • Exchange Rate Effect reached $3.9 million in Q4 2025 per CRL's latest filing, up from -$3.0 million in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $14.9 million in Q4 2022 and bottomed at -$13.4 million in Q4 2024.
  • Average Exchange Rate Effect over 5 years is $2.6 million, with a median of $2.8 million recorded in 2023.
  • Peak YoY movement for Exchange Rate Effect: skyrocketed 122160.0% in 2021, then crashed 20526.67% in 2023.
  • A 5-year view of Exchange Rate Effect shows it stood at $216000.0 in 2021, then surged by 6776.39% to $14.9 million in 2022, then decreased by 14.33% to $12.7 million in 2023, then plummeted by 205.7% to -$13.4 million in 2024, then soared by 129.21% to $3.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Exchange Rate Effect were $3.9 million in Q4 2025, -$3.0 million in Q3 2025, and $12.7 million in Q2 2025.